Pilot treatment for 13 BCR-ABL positive leukemia patients with T315I mutation.

Author: Min ZHOU ¹ ; Xinshan SHA ¹ ; Huiying QIU ¹ ; Jiannong CEN ¹ ; Hongjie SHEN ¹ ; Aining SUN ¹ ; Depei WU ¹
Author Information

1. Key Laboratory of Thrombosis and Haemostasis,Ministry of Health, Jiangsu Institute of Hematology, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Publication Type:Journal Article
MeSH: Adolescent; Adult; Aged; Female; Fusion Proteins, bcr-abl; genetics; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; genetics; therapy; Male; Middle Aged; Mutation; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; genetics; therapy; Retrospective Studies
From: Chinese Journal of Hematology 2014;35(2):162-164
CountryChina
Language:Chinese